User menu

Effect of two oral doses of 17beta-estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double-blind placebo-controlled study.

Bibliographic reference Rousseau, Alexandra ; Robert, Annie ; Gerotziafas, Grigoris ; Torchin, Dahlia ; Zannad, Faiez ; et. al. Effect of two oral doses of 17beta-estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double-blind placebo-controlled study.. In: Fundamental & clinical pharmacology, Vol. 24, no. 2, p. 239-45 (2010)
Permanent URL http://hdl.handle.net/2078.1/25805
  1. Cushman, JAMA, 292, 1573 (2004)
  2. Grady Deborah, Wenger Nanette K., Herrington David, Khan Steven, Furberg Curt, Hunninghake Donald, Vittinghoff Eric, Hulley Stephen, , Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study, 10.7326/0003-4819-132-9-200005020-00002
  3. Hoibraaten, Thromb. Haemost., 84, 961 (2000)
  4. Hulley, JAMA, 280, 605 (1998)
  5. Rossouw, JAMA, 288, 321 (2002)
  6. Pines, Climacteric, 10, 181 (2007)
  7. Stephenson, JAMA, 289, 537 (2003)
  8. Tchaikovski, Thromb. Haemost., 98, 1350 (2007)
  9. Hemker, Pathophysiol. Haemost. Thromb., 33, 4 (2003)
  10. Gerotziafas, Thromb. J., 3, 16 (2005)
  11. Robert Annie, Alliaud Marie-Françoise, Eschwège Valérie, Verdy Elizabeth, Barthet Marie-Christine, Morange Pierre E., Juhan-Vague Irène, Screening for Identified and Unidentified Protein C Pathway Defects by theAgkistrodon contortrixVenom Test in Consecutive Patients, 10.1093/ajcp/112.2.233
  12. Hemelaar, Arterioscler. Thromb. Vasc. Biol., 26, 1660 (2006)
  13. Koh, Arterioscler. Thromb. Vasc. Biol., 23, 1889 (2003)
  14. Oger, Arterioscler. Thromb. Vasc. Biol., 23, 1671 (2003)
  15. Scarabin P.-Y., Alhenc-Gelas M., Plu-Bureau G., Taisne P., Agher R., Aiach M., Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women : A Randomized Controlled Trial, 10.1161/01.atv.17.11.3071
  16. Teede H. J., McGrath B. P., Smolich J. J., Malan E., Kotsopoulos D., Liang Y.-L., Peverill R. E., Postmenopausal Hormone Replacement Therapy Increases Coagulation Activity and Fibrinolysis, 10.1161/01.atv.20.5.1404
  17. Caine, Thromb. Haemost., 68, 392 (1992)
  18. Eilertsen, Maturitas., 55, 278 (2006)
  19. Koh, Arterioscler. Thromb. Vasc. Biol., 24, 1516 (2004)
  20. Dahlback, Lancet, 355, 1627 (2000)
  21. Dielis, J. Thromb. Haemost., 6, 125 (2008)
  22. Butenas, Blood, 94, 2169 (1999)
  23. Gordon, J. Lab. Clin. Med., 111, 52 (1988)
  24. Callejon, Maturitas, 52, 249 (2005)
  25. Johnson Julia V., Lowell Jane, Badger Gary J., Rosing Jan, Tchaikovski Svetlana, Cushman Mary, Effects of Oral and Transdermal Hormonal Contraception on Vascular Risk Markers : A Randomized Controlled Trial, 10.1097/aog.0b013e3181626d1b
  26. Sgarabotto, Thromb. Res., 119, 85 (2007)
  27. Cosman, Thromb. Res., 116, 1 (2005)
  28. Demirol, Menopause, 8, 135 (2001)
  29. Post, Br. J. Haematol., 119, 1017 (2002)
  30. Eilertsen, Thromb. Haemost., 97, 938 (2007)